Coherus was founded a decade ago to provide the highest quality biosimilar treatments to patients. We are proud to now be expanding our legacy—to build on our success with biosimilars and to focus our core strengths on immuno-oncology.
Contact Coherus Biosciences:
Greg Dimuro
gdimuro@coherus.com